Neuroprotective effects of α-lipoic acid and its positively charged amide analogue

Free Radical Biology and Medicine

Volumn 26, Issue 11-12, 1999, Pages 1418-1426

  Tirosh, Oren ^a   Sen, Chandan K ^b   Roy, Sashwati ^a   Kobayashi, Michael S ^a   Packer, Lester ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Biological Technologies   (United States)

Author keywords

Antioxidants; Free radicals; Neurotoxicity; Redox; Thioctic acid

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE; THIOCTIC ACID;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032985492     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00014-3     Document Type: Article

References (32)

1. Kabuto H., Yokoi I., Ogawa N. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia. 39:1998;237-243.
2. Mahle C., Dasgupta A. Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci. 61:1997;437-443.
3. Beit-Yannai E., Zhang R., Trembovler V., Samuni A., Shohami E. Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat. Brain Res. 717:1996;22-28.
4. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
5. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction . J. Neurosci. 18:1998;687-697.
6. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18:1998;205-213.
7. Borlongan C.V., Kanning K., Poulos S.G., Freeman T.B., Cahill D.W., Sanberg P.R. Free radical damage and oxidative stress in Huntington's disease. J. Fla. Med. Assoc. 83:1996;335-341.
8. Smith M.A., Sayre L.M., Anderson V.E., Harris P.L., Beal M.F., Kowall N., Perry G. Cytochemical demonstration of oxidative damage in alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2, 4- dinitrophenylhydrazine [In Process Citation]. J. Histochem. Cytochem. 46:1998;731-736.
9. Zeevalk G.D., Bernard L.P., Nicklas W.J. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J. Neurochem. 70:1998;1421-1430.
10. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease [In Process Citation]. Mov. Disord. 13:(Suppl. 1):1998;24-34.
11. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57:1998;338-342.
12. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
13. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
14. Choi D.W. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2:1990;105-147.
15. Tan S., Sagara Y., Liu Y., Maher P., Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141:1998;1423-1432.
16. Murphy T.H., Schnaar R.L., Coyle J.T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4:1990;1624-1633.
17. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273:1997;R1771-R1778.
18. Kato S., Negishi K., Mawatari K., Kuo C.H. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience. 48:1992;903-914.
19. Froissard P., Monrocq H., Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur. J. Pharmacol. 326:1997;93-99.
20. Pereira C.M., Oliveira C.R. Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic. Biol. Med. 23:1997;637-647.
21. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate pharmacology, mechanisms, and prevention . J. Neurosci. 13:1993;1441-1453.
22. Miyamoto M., Murphy T.H., Schnaar R.L., Coyle J.T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1989;1132-1140.
23. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
24. Sen C.K., Tirosh O., Roy S., Kobayashi M., Packer L. A positively charged a-lipoic acid analogue with increased cellular uptake and more potent immunomodulatory activity. Biochem. Biophys. Res. Commun. 247:1998;223-228.
25. Morimoto B.H., Koshland D.E. Jr. Excitatory amino acid uptake and N-methyl-D-aspartate-mediated secretion in a neural cell line. Proc. Natl. Acad. Sci. USA. 87:1990;3518-3521.
26. Schubert D., Kimura H., Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;8264-8267.
27. Haramaki N., Han D., Handelman G.J., Tritschler H.J., Packer L. Cytosolic and mitochondrial systems for NADH-and NADPH-dependent reduction of alpha-lipoic acid. Free Radic. Biol. Med. 22:1997;535-542.
28. Sen C.K., Roy S., Packer L. Oxidants and antioxidants in glutamate induced cytotoxicity. Packer L., Ong A.S.H. Biological oxidants and antioxidants molecular mechanisms and health effects . 1998;5-13 AOCS Press, Champaign, IL.
29. Bjornstedt M., Kumar S., Bjorkhem L., Spyrou G., Holmgren A. Selenium and the thioredoxin and glutaredoxin systems. Biomed. Environ. Sci. 10:1997;271-279.
30. Marcocci L., Flohe L., Packer L. Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase. Biofactors. 6:1997;351-358.
31. Ghibelli L., Fanelli C., Rotilio G., Lafavia E., Coppola S., Colussi C., Civitareale P., Ciriolo M.R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:1998;479-486.
32. Ghibelli L., Fanelli C., Coppola S., Rotilio G., Lafavia E., Maresca V., Ciriolo M.R. Non-oxidative loss of glutathione in apoptosis via GSH extrusion. Biochem. Soc. Trans. 24:1996;568S.